Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Feb;13(3):249-261.
doi: 10.2217/fon-2016-0223. Epub 2016 Oct 12.

Prognostic outlier genes for enhanced prostate cancer treatment

Hyun Kim  1 , Jenna Skowronski  1 , Robert B Den  1
Affiliations
Review

Prognostic outlier genes for enhanced prostate cancer treatment

Hyun Kim et al. Future Oncol. 2017 Feb.

Abstract

Aim: To review the current landscape of outlier genes in the field of prostate cancer.

Methods: A comprehensive review was performed.

Results: Prostate cancer continues to be a significant worldwide health issue. In the era of personalized medicine, more emphasis is being placed on the ability to determine the timing, intensity and type of treatment, according to each patient's unique disease. Several commercial tests are available to determine the risk of aggressive prostate cancer based on genomic biomarkers and gene expression. Outlier genes represent a form of cancer classification that focuses on bimodal expression of a gene in a specific subset of patients. Outlier genes identified in prostate cancer include TMPRSS2-ERG, SPINK1, ScHLAP1, NVL, SMC4 and SQLE.

Conclusion: Classifying patient prostate cancers by outlier genes may allow for individualized cancer therapies and improved cancer therapy outcomes.

Keywords: biomarkers; biomarkers/oncogenes/molecular; oncology; urologic/prostate.

PubMed Disclaimer

LinkOut - more resources